BioSpace News Archive

Press Releases

ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

February 18, 2026
·
2 min read
Press Releases

Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025

February 18, 2026
·
1 min read
Press Releases

Tango Therapeutics to Report Fourth Quarter 2025 Financial Results and Participate in Three Upcoming Investor Conferences

February 18, 2026
·
1 min read
Press Releases

Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit

February 18, 2026
·
1 min read
Press Releases

Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026

February 18, 2026
·
1 min read
Press Releases

Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight

February 18, 2026
·
23 min read
Press Releases

Enpro Reports Fourth Quarter and Full-Year 2025 Results, Introduces 2026 Guidance

February 18, 2026
·
21 min read
Press Releases

Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine

February 18, 2026
·
5 min read
Press Releases

Korsana Biosciences Emerges from Stealth with $175 Millon in Funding to Advance Potential Best-in-Class Therapeutics for Neurodegenerative Diseases

February 18, 2026
·
5 min read
Press Releases

Cepheid Selected by CDC as National Collaborator, Advancing Rapid Diagnostic Innovation to Strengthen U.S. Pandemic Preparedness

February 18, 2026
·
4 min read